Modern Action logo
IssuesBillsBriefingNewsletterAbout
Donate
Donate
Modern Action

Navigation

Menu

01HomeFront page→02IssuesActive issue pages→03BillsLegislation index→04BriefingDaily context→05NewsletterWeekly Watchlist→06AboutMission and team→07DonateSupport the work→

Account

Sign In→Get Started→
Modern Action

Find the bills behind the news, understand what Congress can do, and contact your representatives with a specific message.

Platform

  • Contact Congress
  • Write to Congress
  • Browse Bills
  • Track Bills

Resources

  • Find My Representatives
  • Contact My Representatives
  • How to Contact Representatives
  • Does Contacting Congress Work?
  • Newsletter

Support

  • About
  • Contact Us
  • Press
  • Accessibility

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Accessibility

Stay informed about legislation

Get weekly updates on important bills and how to take action.

© 2026 Modern Action. All rights reserved.

Made with ❤️ for democracy
All systems operational

Contact Congress about H.R. 3493: Global Fairness in Drug Pricing Act

This bill would push the government to tie some U.S. drug prices to lower prices in other developed countries. It would also expand paths for safe drug importation, support direct sales from drug makers, and press antitrust agencies to police drug company conduct more closely.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Global Fairness in Drug Pricing Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 3493: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects people who buy prescription drugs in the United States, especially patients who face high prices. It also directly affects drug manufacturers, federal health agencies, antitrust regulators, and people who might try to import lower-cost drugs from certain developed countries. Insurers and government health programs could also be affected if drug prices change.

Why this matters: Prescription drugs often cost more in the United States than in other wealthy countries, and this bill tries to narrow that gap. If it works, patients, insurers, and public programs could pay less. It could also change how drug companies price their products and how closely federal agencies watch their business practices. Some parts would depend on later rulemaking and agency action, so the full effect is still uncertain.

Key provisions in H.R. 3493

  • Health and Human Services would have 30 days to draft a rulemaking plan for drug price targets. It must do this with Medicare, Medicaid, and other agencies.
  • The bill aims to bring U.S. drug prices closer to what people pay in similar developed countries.
  • Health and Human Services could not open the door to broad personal drug importation right away. It would first have to tell Congress that importation under current law is safe and would cut costs a lot for U.S. patients.
  • Health and Human Services would have to spell out when a person could get a waiver to import a prescription drug. These waivers would be decided one case at a time for drugs from developed countries with lower prices.
  • The Attorney General and the Federal Trade Commission would be told to use current antitrust laws against drug makers when the law allows. That includes parts of the Sherman Act and the Federal Trade Commission Act aimed at blocking unfair anti-competitive conduct.

How Modern Action helps you take action on H.R. 3493

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 3493

What is H.R. 3493?
This bill would push the government to tie some U.S. drug prices to lower prices in other developed countries. It would also expand paths for safe drug importation, support direct sales from drug makers, and press antitrust agencies to police drug company conduct more closely.
How do I support or oppose H.R. 3493?
Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.
Who should I contact about H.R. 3493?
Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.
Can Modern Action explain H.R. 3493 before I act?
Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.